The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.
Fiche publication
Date publication
juillet 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MIRJOLET Céline, Pr PAUL Catherine, Pr TRUC Gilles, Pr MILLOT Nadine
Tous les auteurs :
Mirjolet C, Papa AL, Crehange G, Raguin O, Seignez C, Paul C, Truc G, Maingon P, Millot N
Lien Pubmed
Résumé
BACKGROUND AND PURPOSE: One of the new challenges to improve radiotherapy is to increase the ionizing effect by using nanoparticles. The interest of titanate nanotubes (TiONts) associated with radiotherapy was evaluated in two human glioblastoma cell lines (SNB-19 and U87MG). MATERIALS AND METHODS: Titanate nanotubes were synthetized by the hydrothermal treatment of titanium dioxide powder in a strongly basic NaOH solution. The cytotoxicity of TiONts was evaluated on SNB-19 and U87MG cell lines by cell proliferation assay. The internalization of TiONts was studied using Transmission Electron Microscopy (TEM). Finally, the effect of TiONts on cell radiosensitivity was evaluated using clonogenic assay. Cell cycle distribution was evaluated by flow cytometry after DNA labeling. DNA double-stranded breaks were evaluated using gammaH2AX labeling. RESULTS: Cells internalized TiONts through the possible combination of endocytosis and diffusion with no cytotoxicity. Clonogenic assays showed that cell lines incubated with TiONts were radiosensitized with a decrease in the SF2 parameter for both SNB-19 and U87MG cells. TiONts decreased DNA repair efficiency after irradiation and amplified G2/M cell-cycle arrest. CONCLUSION: Our results indicated that further development of TiONts might provide a new useful tool for research and clinical therapy in the field of oncology.
Référence
Radiother Oncol. 2013 Jul;108(1):136-42